LexaGene Provides Update on Commercializing its Automated Pathogen Detection System
01 juin 2020 08h49 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., June 01, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”) a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Places a Pre-Commercial Instrument for COVID-19 Testing in a Major Hospital Laboratory
28 mai 2020 07h55 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Holdings Receives Approval to Amend Warrant Terms
08 mai 2020 22h36 HE
|
LexaGene Holdings Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., May 08, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB:...
LexaGene Holdings Proposes to Amend Warrants Terms and Announces a Strategic Marketing Promotional Campaign
23 avr. 2020 17h00 HE
|
LexaGene Holdings Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB:...
LexaGene Files Patent Application for Expanded Capabilities of Their LX Analyzer
16 avr. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Appoints Dr. Eleanor Kolossovski to Director of Product Marketing
01 avr. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., April 01, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Appoints Steven Armstrong to Senior Director of Operations
24 mars 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., March 24, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Provides Update on the Exercise of Warrants
17 mars 2020 15h07 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene Provides Corporate Update
11 mars 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., March 11, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen...
LexaGene’s LX Analyzer Successfully Detects Coronavirus RNA using the CDC’s Tests
20 févr. 2020 07h58 HE
|
LexaGene Holdings Inc
BEVERLY, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a biotechnology company that develops genetic analyzers for...